Location out of bounds

Molecular Oncology

Innovative diagnostic and prognostic testing in blood cancers

Client Services

Email 800-245-3117 x 6250 Request Information Online Ordering Portal Forms & Requisitions Accreditations and Licenses

Molecular Oncology Survey

To better serve hospitals and physicians with patient treatment, we would like your input again regarding Hematologic Oncology Sequencing testing. To aid in providing this input, we are conducting a brief survey. The questionnaire should take less than two minutes to complete.

Complete Our Short Survey

Versiti provides innovative diagnostic and prognostic testing in blood cancers to support patient stratification and therapeutic decisions. We deliver novel testing services that provide critical clinical direction in complex cases of acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) and chronic myelogenous leukemia (CML). Our testing menus are built around testing algorithms as recommended by the National Comprehensive Cancer Network (NCCN) and the World Health Organization (WHO).

ic-arrow-right
x

This website uses cookies to ensure you get the best experience on our website. Learn more